University of Aberdeen, Aberdeen, UK.
Ann Rheum Dis. 2010 Oct;69(10):1744-50. doi: 10.1136/ard.2009.119032. Epub 2010 May 6.
The systemic vasculitides are multiorgan diseases where early diagnosis and treatment can significantly improve outcomes. Robust nomenclature reduces diagnostic delay. However, key aspects of current nomenclature are widely perceived to be out of date, these include disease definitions, classification and diagnostic criteria. Therefore, the aim of the present work was to identify deficiencies and provide contemporary points to consider for the development of future definitions and criteria in systemic vasculitis.
The expert panel identified areas of concern within existing definitions/criteria. Consequently, a systematic literature review was undertaken looking to address these deficiencies and produce 'points to consider' in accordance with standardised European League Against Rheumatism (EULAR) operating procedures. In the absence of evidence, expert consensus was used.
There was unanimous consensus for re-evaluating existing definitions and developing new criteria. A total of 17 points to consider were proposed, covering 6 main areas: biopsy, laboratory testing, diagnostic radiology, nosology, definitions and research agenda. Suggestions to improve and expand current definitions were described including the incorporation of anti-neutrophil cytoplasm antibody and aetiological factors, where known. The importance of biopsy in diagnosis and exclusion of mimics was highlighted, while equally emphasising its problems. Thus, the role of alternative diagnostic tools such as MRI, ultrasound and surrogate markers were also discussed. Finally, structures to develop future criteria were considered.
Limitations in current classification criteria and definitions for vasculitis have been identified and suggestions provided for improvement. Additionally it is proposed that, in combination with the updated evidence, these should form the basis of future attempts to develop and validate revised criteria and definitions of vasculitis.
系统性血管炎是多器官疾病,早期诊断和治疗可以显著改善预后。稳健的命名法可以减少诊断延迟。然而,当前命名法的关键方面被广泛认为已经过时,这些方面包括疾病定义、分类和诊断标准。因此,本研究的目的是确定不足之处,并为未来系统性血管炎的定义和标准制定提供当代的考虑要点。
专家小组确定了现有定义/标准中的关注领域。因此,进行了系统的文献回顾,旨在解决这些不足,并根据标准的欧洲抗风湿病联盟 (EULAR) 操作规程提出“考虑要点”。在缺乏证据的情况下,使用了专家共识。
对于重新评估现有定义和制定新的标准,存在一致的共识。提出了总共 17 个考虑要点,涵盖了 6 个主要领域:活检、实验室检查、诊断影像学、命名法、定义和研究议程。提出了改进和扩展当前定义的建议,包括纳入抗中性粒细胞胞质抗体和已知病因因素。强调了活检在诊断和排除类似疾病中的重要性,同时也强调了其存在的问题。因此,还讨论了替代诊断工具,如 MRI、超声和替代标志物的作用。最后,考虑了制定未来标准的结构。
已经确定了当前血管炎分类标准和定义的局限性,并提出了改进建议。此外,建议将这些建议与更新的证据相结合,作为未来尝试制定和验证血管炎修订标准和定义的基础。